Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2005
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experimentL G Mantovani, M S Monzini, P M Mannucci, et al.
Acta Chirurgica Belgica|February 6, 2014
Use of health-related quality-of-life measurements to estimate individuals' health on screeningL Scalone, P A Cortesi, G Spinella, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2015
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent HepatitisP A Cortesi, L G Mantovani, A Ciaccio, et al.
Journal of Chemotherapy (Florence, Italy)|May 4, 2010
Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patientsS De Portu, L G Mantovani, A Ravaioli, et al.
Public Health|January 17, 2022
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studiesP Ferrara, D Ponticelli, F Agüero, et al.
Journal of Viral Hepatitis|February 7, 2018
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunitiesP A Cortesi, L S Belli, R Facchetti, et al.
Journal of Viral Hepatitis|July 22, 2014
Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment optionsP A Cortesi, A Ciaccio, M Rota, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2012
Haemophilia care in Europe: the ESCHQoL studyW Schramm, A Gringeri, R Ljung, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsJ Astermark, A Rocino, M Von Depka, et al.
Rheumatology (Oxford, England)|August 30, 2008
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyI Olivieri, S de Portu, C Salvarani, et al.
Pageof 3